Skip to content

Virtuix Holdings Inc. VTIX Issuance of warrants

Issuance of warrants at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.52M-75.7%
Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
$91.49K
SVC
Stellar V Capital Corp. Class A Ordinary SharesSVCC
$1.22M
Evommune
 logo
Evommune EVMN
$150
CO2 Energy Transition Corp. Common Stock logo
CO2 Energy Transition Corp. Common StockNOEM
$51.75K
ADMA Biologics logo
ADMA BiologicsADMA
$1.4M

Other financials

Income statement

See full
Revenue$1.3M-14.0%
Gross profit$173.6K
Operating income-$4.9M-98.1%
Net income-$9.9M-277%
EPS (diluted)-$0.39-21.9%

Balance sheet

See full
Cash & equivalents$9.5M+1,882%
Total debt$3.2M+273%
Total equity$3.0M+484%
Total assets$14.8M+156%

Cash flow

See full
Operating cash flow-$4.0M-156%

Valuation

See full
Market cap$100.34M-69.9%
Enterprise value$94.08M
P/S20.2×

Profitability

See full
Gross margin11.5%
Operating margin-221.9%
Net margin-337.4%

Returns & leverage

See full
Return on equity-1,490.6%
Debt / equity1.1×
Current ratio1.4×+1.0×

Where this comes from

Reported directly by Virtuix Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: Virtuix Holdings Inc. ’s 10-Q, filed March 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Virtuix Holdings Inc. 's issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Virtuix Holdings Inc. 's issuance of warrants?
Virtuix Holdings Inc. (VTIX) reported issuance of warrants of $717.95K in Q4 2025.